Can you provide custom packaging?

Yes, we support OEM/ODM services for customized branding.

What certifications do you hold?

We hold GMP, COPP, CP, BP, and ISO9001 certifications.

Levonorgestrel Emergency Contraceptive Tablet 1.5mg for Safe Choices

Name: Levonorgestrel Emergency Contraceptive Tablet 1.5mg for Safe Choices
Brand: Jiangxi Serum Pharma Industries Co., Ltd.
SKU: 2121406275

Jiangxi, ChinaJiangxi Serum Pharma Industries Co., Ltd.

US$0.50-999.00

1,000,000 boxes

Sample price:US$80.00/piece.Request sample

Product profile

Customization

Available

Powder

Customized

Model NO.

ANTI-06-5

Certification

GMP, Copp

Suitable for

Elderly, Children, Adult

State

Solid

Purity

>99%

Transport Package

Level 3

Specification

1.5mg

Trademark

Serumpharm

Origin

China

HS Code

2901231000

Key features

High Purity Level: Purity exceeds 99% ensuring maximum efficacy and safety.

OEM/ODM Support: Full customization services available for branding and packaging.

Global Certifications: Certified under GMP, COPP, CP, BP, and ISO9001 standards.

Wide Age Suitability: Safe and effective for adults, children, and the elderly.

Fast Delivery: Standard delivery time ranges from 30 to 60 days.

Flexible Payment: Accepts T/T, L/C, D/P, PayPal, and Western Union.

Established Manufacturer: Over 20 years of experience in pharmaceutical manufacturing.

Global Export Reach: Products exported to over 60 countries worldwide.

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceExperienced Team

Jiangxi Serum Pharma Industries Co., Ltd.

Jiangxi, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2024-04-17Nearest Port: SHANGHAIAverage Response Time: ≤8.09hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, CFR

AI-Powered supplier vetting

SummaryJiangxi Serum Pharma Industries Co., Ltd. is a limited company offering human medicines, medical consumables, medical devices, disinfectants, and veterinary medicines. It holds ISO 13485, ISO 9001, and GMP certifications, has documented service, corrective-action, and complaint-handling procedures, and reports valid import/export licensing with 90% of sales from exports. The supplier provides broad customization, ODM, and OEM services, and has cooperated with domestic biological-product, vaccine, API, and auxiliary-material manufacturers. However, no new products were reported in the past year, no SDK is available, raw-material traceability status is unknown, and sustainability-related compliance statuses are also unknown. Production scale and organizational information are limited and should be verified further.

Supplier typeThe supplier is identified as a limited company with no larger-company affiliation. Its stated product scope covers human medicine, medical consumables, medical devices, disinfectants, and veterinary medicine, indicating a diversified pharmaceutical and healthcare supplier profile.

CertificationsThe supplier reports holding ISO 13485, ISO 9001, and GMP certifications. These certifications directly support quality-management and pharmaceutical/medical-product compliance, although the provided slices do not show certificate validity dates or scope details.

After-Sales capabilityThe supplier states that it provides after-sales service, while its service-capability assessment, corrective and preventive action, and customer-complaint processes are documented and supported by followed records. This provides explicit evidence of a structured service and complaint-management system.

Customization capabilityThe supplier explicitly supports customization from samples, designs, full customization, minor customization, and flexible customization. Its ODM and OEM capabilities further support tailored product development and manufacturing.

Client casesThe supplier reports close cooperation with domestic manufacturers of biological products, vaccines, APIs, and auxiliary materials, provides OEM services for well-known brands, has participated in the CPHI offline trade show, and has exported for seven years with 90% of sales from exports. These are relevant experience indicators, but no named customers, project details, or independently verifiable case outcomes are provided.